REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 81 filers reported holding REATA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $929,000 | +115.0% | 11,363 | -8.1% | 0.01% | +120.0% |
Q2 2018 | $432,000 | -99.8% | 12,363 | 0.0% | 0.01% | +66.7% |
Q1 2018 | $253,565,000 | -21.2% | 12,363 | +8.8% | 0.00% | -25.0% |
Q4 2017 | $321,800,000 | -8.9% | 11,363 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $353,389,000 | -1.7% | 11,363 | 0.0% | 0.00% | -20.0% |
Q2 2017 | $359,525,000 | -27.1% | 11,363 | -49.7% | 0.01% | -28.6% |
Q1 2017 | $493,096,000 | +99919.5% | 22,588 | 0.0% | 0.01% | 0.0% |
Q4 2016 | $493,000 | -99.8% | 22,588 | +98.8% | 0.01% | +75.0% |
Q3 2016 | $299,528,000 | +33.5% | 11,363 | 0.0% | 0.00% | +33.3% |
Q2 2016 | $224,419,000 | – | 11,363 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |